BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15774549)

  • 1. 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.
    Kaplan BL; Ouyang Y; Rockwell CE; Rao GK; Kaminski NE
    J Leukoc Biol; 2005 Jun; 77(6):966-74. PubMed ID: 15774549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
    Rockwell CE; Snider NT; Thompson JT; Vanden Heuvel JP; Kaminski NE
    Mol Pharmacol; 2006 Jul; 70(1):101-11. PubMed ID: 16611855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).
    Kaplan BL; Springs AE; Kaminski NE
    Biochem Pharmacol; 2008 Sep; 76(6):726-37. PubMed ID: 18656454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells.
    Ouyang Y; Hwang SG; Han SH; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):676-83. PubMed ID: 9547358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells.
    Rockwell CE; Raman P; Kaplan BL; Kaminski NE
    Biochem Pharmacol; 2008 Aug; 76(3):353-61. PubMed ID: 18571623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species.
    Siegmund SV; Qian T; de Minicis S; Harvey-White J; Kunos G; Vinod KY; Hungund B; Schwabe RF
    FASEB J; 2007 Sep; 21(11):2798-806. PubMed ID: 17440119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells.
    Raman P; Kaplan BL; Kaminski NE
    J Pharmacol Exp Ther; 2012 Sep; 342(3):816-26. PubMed ID: 22700433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CB1 mRNA upon activation of murine splenocytes.
    Noe SN; Newton C; Widen R; Friedman H; Klein TW
    Adv Exp Med Biol; 2001; 493():215-21. PubMed ID: 11727768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
    Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
    PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.
    Kaplan BL; Ouyang Y; Herring A; Yea SS; Razdan R; Kaminski NE
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):107-15. PubMed ID: 15893538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor.
    He F; Qiao ZH; Cai J; Pierce W; He DC; Song ZH
    Mol Pharmacol; 2007 Nov; 72(5):1289-300. PubMed ID: 17698952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK; Kaminski NE
    J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aqueous humor outflow effects of 2-arachidonylglycerol.
    Njie YF; He F; Qiao Z; Song ZH
    Exp Eye Res; 2008 Aug; 87(2):106-14. PubMed ID: 18597752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells.
    Zhao Q; He Z; Chen N; Cho YY; Zhu F; Lu C; Ma WY; Bode AM; Dong Z
    J Biol Chem; 2005 Jul; 280(29):26735-42. PubMed ID: 15886210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.
    Lee M; Yang KH; Kaminski NE
    J Pharmacol Exp Ther; 1995 Nov; 275(2):529-36. PubMed ID: 7473135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes.
    Kaplan BL; Rockwell CE; Kaminski NE
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1077-85. PubMed ID: 12805480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids selectively enhance sweet taste.
    Yoshida R; Ohkuri T; Jyotaki M; Yasuo T; Horio N; Yasumatsu K; Sanematsu K; Shigemura N; Yamamoto T; Margolskee RF; Ninomiya Y
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):935-9. PubMed ID: 20080779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
    Shoemaker JL; Ruckle MB; Mayeux PR; Prather PL
    J Pharmacol Exp Ther; 2005 Nov; 315(2):828-38. PubMed ID: 16081674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.